1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Optimizing Maternal RSV Immunization Delivery: A Systems Based Quality Improvement Initiative to Improve Uptake, Equity, and Newborn Outcomes is sponsored by Pfizer, Inc.. This initiative from Pfizer, Inc. focuses on quality improvement to enhance the delivery of maternal RSV immunization, aiming to improve uptake, equity, and newborn outcomes.
While not directly pharmacovigilance, it relates to drug safety through immunization delivery and outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Universities and other research-conducting organizations are likely eligible, but specific details should be confirmed on the official Pfizer grant announcement. Confirm the full requirements in the official notice before applying.
Optimizing Maternal RSV Immunization Delivery: A Systems Based Quality Improvement Initiative to Improve Uptake, Equity, and Newborn Outcomes is funded by Pfizer, Inc.. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program